33 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
23 Jan 19
51-102F3 Material Change Report
12:44pm
Instrument 61-101 Protection of Minority Security Holders in Special Transactions (“MI 61-101”) and each issuance is considered to be a “related party … in section 5.5(b) as the Company’s shares are not listed on a specified market and from the minority shareholder approval requirements of MI 61-101
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
18 May 23
RepliCel Applies to Extend Warrant and Stock Option Expiry Dates and Announces Grant of Stock Options
1:58pm
of Minority Security Holders in Special Transactions (“MI 61-101”) and each extension is considered to be a “related party transaction” within the meaning … ) as the Company’s shares are not listed on a specified market and from the minority shareholder approval requirements of MI 61-101 by virtue of the exemption
6-K
EX-99.8
REPCF
Replicel Life Sciences Inc.
18 Aug 21
Current report (foreign)
12:20pm
party” within the meaning of Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions (“MI 61-101”) and each … the minority shareholder approval requirements of MI 61-101 by virtue of the exemption contained in section 5.7(a) of MI 61-101 in that the fair market value
6-K
EX-99.5
REPCF
Replicel Life Sciences Inc.
10 May 22
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
4:34pm
of Minority Security Holders in Special Transactions (“MI 61-101”) but the issuance was exempt from the valuation requirement of MI 61-101 by virtue … of the exemption contained in section 5.5(b) as the Company’s shares are not listed on a specified market and from the minority shareholder approval
6-K
EX-99.5
REPCF
Replicel Life Sciences Inc.
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am
to be a "related party" within the meaning of Multilateral Instrument 61-101 Protection of Minority Security Holders in Special Transactions ("MI 61-101 … and from the minority shareholder approval requirements of MI 61-101 by virtue of the exemption contained in section 5.7(a) of MI 61-101 in that the fair
6-K
EX-99.3
vqs3bxwxj436yc1
8 Sep 20
Replicel Announces Extension to Private Placement
7:14pm
6-K
EX-99.1
28g 4yvtyx41s92
20 Sep 19
51-102F3 Material Change Report
1:31pm
6-K
EX-99.3
jlpx3lvfgi
8 Sep 20
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
1:17pm
6-K
EX-99.1
9xwqu9u6mpzqwcw3qk
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.2
f9qylhrvfvtxogo
18 Aug 21
RepliCel Life Sciences Announces Closing of Debt Settlement
12:34pm
6-K
EX-99.1
an9huigxobt8qx59agmz
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.2
n49wemak
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.3
9vca2gu4c km0an9
11 Sep 19
51-102F3 Material Change Report
12:13pm
6-K
EX-99.3
bgw0 3p0dq
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.2
r4e7xh 1c4l0sgqe
13 Aug 21
RepliCel Life Sciences Announces Debt Settlement
12:00am
6-K
EX-99.1
2tw9q24nw 6k
13 Aug 21
51-102F3 Material Change Report
12:00am
6-K
EX-99.2
my93fffcactcfy2 6p
29 Mar 22
RepliCel Announces Non-brokered Private Placement
1:02pm
6-K
EX-99.4
3kum5khc0sq p40i1
8 Sep 20
Replicel Life Sciences Inc. Announces Application for a Management Cease Trade Order
1:17pm
6-K
EX-99.7
iiecupw80s
18 Aug 21
Current report (foreign)
12:20pm
6-K
EX-99.2
b4r7mbq
20 Mar 24
RepliCel announces a Letter of Intent for Asset Purchase Agreement
4:38pm